Innovate UK's Therapeutics Portfolio

Epsilogen is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.

SynaptixBio is a biotechnology research company that develops lifesaving therapies for severe leukodystrophies.

Biotech is a biotechnology company that develops cancer therapies.

VaxEquity is a biotechnology company that develops RNA therapeutics and vaccines.

Thalia Therapeutics is a drug reformulation company.

CGT Catapult is a centre of innovation, with the core purpose of building cell and gene therapy sector in the UK.

NeoPhore is a provider of novel small molecule therapies intended to treat cancer through stimulation of the immune system.

Elasmogen is a precision biologics drug discovery company that develops soloMERs.

Kynos Therapeutics develops KMO inhibitors across key indications in inflammation, immunity, and metabolism.

Mosaic Therapeutics is an oncology therapeutics company that develops targeted combination therapies for cancer patients.

Theolytics is a clinical stage biotechnology company developing next-generation viral therapies.

Mestag Therapeutics is a biotechnology company that develops new therapies for diseases using fibroblast technology.

Maxion Therapeutics helps in learning transformative therapies.

Freeline is a biotechnology company that develops transformative gene therapies for systemic debilitating diseases.

Centauri Therapeutics is a UK-based biotechnology company focused on the discovery and development of life threatening diseases.

MISSION Therapeutics develops therapies that enhance the removal of dysfunctional mitochondria to combat serious diseases.

StimOxyGen specializes in developing innovative, pH-responsive nanoparticles designed to generate oxygen in hypoxic tumors.

VR software, Web Application

Dia Beta Labs is the research group's official commercial vehicle, advancing lead assets into late-stage preclinical development.

Pathios Therapeutics is a biotech company focused on the development of therapies for autoimmune diseases and cancer.

Metallo Bio's focus is on the development of two lead chemicals that represent a pioneering new class of antibiotics.

Neobe Therapeutics provides immunotherapies, clinical trials, research, and tumor-colonizing bacteria engineering services.

NK:IO is a biotech company that develops novel approaches to natural killer cell-mediated immunotherapy.

Mesenbio is a preclinical biopharmaceutical business based at the University of York.

Sixfold Bioscience develops and researches on biotechnology advances for RNA therapies.

XR Therapeutics is a start-up company, spun out of Newcastle University which has been based on over a decade of academic research.

Camallergy develops and provides new treatments for common food allergies.

Multus is a global leader in cell culture media design for cell-based biomanufacturing, combining AI, robotic automation, and cell biology.

Developing personalised digital healthcare solutions to improve outcomes for patients and clinicians